位置:首页 > 蛋白库 > PKS18_MYCTU
PKS18_MYCTU
ID   PKS18_MYCTU             Reviewed;         393 AA.
AC   P9WPF1; L0T6G2; Q79FQ0; Q7D8I1;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 36.
DE   RecName: Full=Alpha-pyrone synthesis polyketide synthase-like Pks18;
DE            EC=2.3.1.- {ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723, ECO:0000269|PubMed:15984864};
DE   AltName: Full=Alpha-pyrone synthesis polyketide synthase type III Pks18;
DE   AltName: Full=Chalcone synthase-like protein;
DE            Short=CHS-like;
GN   Name=pks18; OrderedLocusNames=Rv1372;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   FUNCTION AS A POLYKETIDE SYNTHASE, STARTER UNIT SPECIFICITY, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF ALA-148;
RP   LYS-318 AND LEU-348.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=12941968; DOI=10.1074/jbc.m306714200;
RA   Saxena P., Yadav G., Mohanty D., Gokhale R.S.;
RT   "A new family of type III polyketide synthases in Mycobacterium
RT   tuberculosis.";
RL   J. Biol. Chem. 278:44780-44790(2003).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15984864; DOI=10.1021/ja052991s;
RA   Arora P., Vats A., Saxena P., Mohanty D., Gokhale R.S.;
RT   "Promiscuous fatty acyl CoA ligases produce acyl-CoA and acyl-SNAC
RT   precursors for polyketide biosynthesis.";
RL   J. Am. Chem. Soc. 127:9388-9389(2005).
RN   [4] {ECO:0007744|PDB:1TED, ECO:0007744|PDB:1TEE}
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF MUTANT PHE-205 IN COMPLEX WITH
RP   SUBSTRATE, FUNCTION, CATALYTIC ACTIVITY, STARTER UNIT SPECIFICITY, SUBUNIT,
RP   ACTIVE SITE, AND MUTAGENESIS OF THR-144; CYS-175; CYS-205; ALA-209 AND
RP   CYS-275.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=15286723; DOI=10.1038/nsmb809;
RA   Sankaranarayanan R., Saxena P., Marathe U.B., Gokhale R.S., Shanmugam V.M.,
RA   Rukmini R.;
RT   "A novel tunnel in mycobacterial type III polyketide synthase reveals the
RT   structural basis for generating diverse metabolites.";
RL   Nat. Struct. Mol. Biol. 11:894-900(2004).
CC   -!- FUNCTION: Involved in the biosynthesis of tri- and tetraketide alpha-
CC       pyrones. Pks18 catalyzes the extension of medium- and long-chain
CC       aliphatic acyl-CoA substrates by using malonyl-CoA as an extender
CC       molecule to synthesize polyketide products.
CC       {ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723,
CC       ECO:0000269|PubMed:15984864}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + hexanoyl-CoA + 2 malonyl-CoA = 4-hydroxy-6-
CC         pentylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:43452,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:62620, ChEBI:CHEBI:66958;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43453;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + 2 malonyl-CoA + octanoyl-CoA = 4-hydroxy-6-
CC         heptylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:44284,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:57386, ChEBI:CHEBI:84246;
CC         Evidence={ECO:0000269|PubMed:15286723};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44285;
CC         Evidence={ECO:0000269|PubMed:15286723};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-hydroxy-6-
CC         undecylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:43460,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:57384, ChEBI:CHEBI:84149;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723,
CC         ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43461;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723,
CC         ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-6-(2-
CC         oxotridecyl)pyran-2-one + 3 CO2 + 4 CoA; Xref=Rhea:RHEA:43368,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:57384, ChEBI:CHEBI:84150;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723,
CC         ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43369;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723,
CC         ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + hexadecanoyl-CoA + 2 malonyl-CoA = 4-hydroxy-6-
CC         pentadecylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:44260,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:57384, ChEBI:CHEBI:84168;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44261;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 H(+) + hexadecanoyl-CoA + 3 malonyl-CoA = 4-hydroxy-6-(2-
CC         oxoheptadecyl)pyran-2-one + 3 CO2 + 4 CoA; Xref=Rhea:RHEA:44268,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:57384, ChEBI:CHEBI:84171;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44269;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15286723};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + 2 malonyl-CoA + octadecanoyl-CoA = 4-hydroxy-6-
CC         heptadecylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:44280,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:57394, ChEBI:CHEBI:84169;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44281;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 H(+) + 3 malonyl-CoA + octadecanoyl-CoA = 4-hydroxy-6-(2-
CC         oxononadecyl)pyran-2-one + 3 CO2 + 4 CoA; Xref=Rhea:RHEA:44272,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:57394, ChEBI:CHEBI:84172;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44273;
CC         Evidence={ECO:0000269|PubMed:12941968, ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-hydroxy-6-
CC         nonadecylpyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:44264,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57380, ChEBI:CHEBI:57384, ChEBI:CHEBI:84170;
CC         Evidence={ECO:0000269|PubMed:12941968};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44265;
CC         Evidence={ECO:0000269|PubMed:12941968};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-6-(2-
CC         oxohenicosyl)pyran-2-one + 3 CO2 + 4 CoA; Xref=Rhea:RHEA:44276,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57380, ChEBI:CHEBI:57384, ChEBI:CHEBI:84173;
CC         Evidence={ECO:0000269|PubMed:12941968};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44277;
CC         Evidence={ECO:0000269|PubMed:12941968};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-decenoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-hydroxy-6-(non-8-
CC         en-1-yl)-pyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:45868,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:84214, ChEBI:CHEBI:85479;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45869;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-decenoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-6-(2-
CC         oxoundec-10-en-1-yl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45924, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84214,
CC         ChEBI:CHEBI:85494; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45925;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxytetradecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-
CC         hydroxy-6-(2-hydroxytridecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45856, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84198,
CC         ChEBI:CHEBI:85474; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45857;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-hydroxypentadecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-
CC         hydroxy-6-(14-hydroxytetradecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45872, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84205,
CC         ChEBI:CHEBI:85481; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45873;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-hydroxypentadecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-
CC         hydroxy-6-(16-hydroxy-2-oxohexadecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45928, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84205,
CC         ChEBI:CHEBI:85495; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45929;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=16-hydroxyhexadecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-
CC         hydroxy-6-(15-hydroxypentadecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45864, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84207,
CC         ChEBI:CHEBI:85477; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45865;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=16-hydroxyhexadecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-
CC         hydroxy-6-(17-hydroxy-2-oxoheptadecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45920, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84207,
CC         ChEBI:CHEBI:85492; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45921;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hydroxyoctadecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-
CC         hydroxy-6-(11-hydroxyheptadecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45860, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84202,
CC         ChEBI:CHEBI:85475; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45861;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hydroxyoctadecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-
CC         hydroxy-6-(13-hydroxy-2-oxononadecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45916, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84202,
CC         ChEBI:CHEBI:85490; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45917;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylhexadecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 6-
CC         (hexadecan-2-yl)-4-hydroxy-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45876, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84182,
CC         ChEBI:CHEBI:85482; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45877;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-methylhexadecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-
CC         6-(3-methyl-2-oxoheptadecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45932, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84182,
CC         ChEBI:CHEBI:85496; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45933;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-methylundecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-hydroxy-6-
CC         (2-methyldecyl)-pyran-2-one + 2 CO2 + 3 CoA; Xref=Rhea:RHEA:45880,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:84183, ChEBI:CHEBI:85483;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45881;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-methylundecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-6-
CC         (4-methyl-2-oxododecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45936, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84183,
CC         ChEBI:CHEBI:85497; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45937;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-methyltridecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-hydroxy-
CC         6-(11-methyldodecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45888, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84195,
CC         ChEBI:CHEBI:85485; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45889;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-methyltridecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-hydroxy-
CC         6-(13-methyl-2-oxotetradecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45944, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84195,
CC         ChEBI:CHEBI:85499; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45945;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-methyloctadecanoyl-CoA + 2 H(+) + 2 malonyl-CoA = 4-
CC         hydroxy-6-(11-methylheptadecyl)-pyran-2-one + 2 CO2 + 3 CoA;
CC         Xref=Rhea:RHEA:45884, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84181,
CC         ChEBI:CHEBI:85484; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45885;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-methyloctadecanoyl-CoA + 3 H(+) + 3 malonyl-CoA = 4-
CC         hydroxy-6-(13-methyl-2-oxononadecyl)pyran-2-one + 3 CO2 + 4 CoA;
CC         Xref=Rhea:RHEA:45940, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:84181,
CC         ChEBI:CHEBI:85498; Evidence={ECO:0000269|PubMed:15984864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45941;
CC         Evidence={ECO:0000269|PubMed:15984864};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.2 uM for lauroyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC         KM=5.4 uM for palmitoyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC         KM=6.1 uM for arachidoyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC         KM=19.2 uM for hexanoyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC         KM=49.2 uM for acetyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC         KM=58.4 uM for malonyl-CoA (at 30 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:12941968};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000305}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15286723}.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. Chalcone/stilbene
CC       synthases family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP44131.1; -; Genomic_DNA.
DR   PIR; A70958; A70958.
DR   RefSeq; WP_003407185.1; NZ_NVQJ01000050.1.
DR   RefSeq; YP_177803.1; NC_000962.3.
DR   PDB; 1TED; X-ray; 2.25 A; A/B/C/D=1-393.
DR   PDB; 1TEE; X-ray; 2.90 A; A/B/C/D=1-393.
DR   PDBsum; 1TED; -.
DR   PDBsum; 1TEE; -.
DR   AlphaFoldDB; P9WPF1; -.
DR   SMR; P9WPF1; -.
DR   STRING; 83332.Rv1372; -.
DR   DrugBank; DB08231; Myristic acid.
DR   SwissLipids; SLP:000001035; -.
DR   PaxDb; P9WPF1; -.
DR   DNASU; 886797; -.
DR   GeneID; 886797; -.
DR   KEGG; mtu:Rv1372; -.
DR   TubercuList; Rv1372; -.
DR   eggNOG; COG3424; Bacteria.
DR   OMA; PIWGLGC; -.
DR   PhylomeDB; P9WPF1; -.
DR   SABIO-RK; P9WPF1; -.
DR   UniPathway; UPA00094; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0016747; F:acyltransferase activity, transferring groups other than amino-acyl groups; IBA:GO_Central.
DR   GO; GO:0009715; P:chalcone biosynthetic process; IDA:MTBBASE.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0030639; P:polyketide biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR012328; Chalcone/stilbene_synt_C.
DR   InterPro; IPR001099; Chalcone/stilbene_synt_N.
DR   InterPro; IPR011141; Polyketide_synthase_type-III.
DR   InterPro; IPR016039; Thiolase-like.
DR   PANTHER; PTHR11877; PTHR11877; 1.
DR   Pfam; PF02797; Chal_sti_synt_C; 1.
DR   Pfam; PF00195; Chal_sti_synt_N; 1.
DR   PIRSF; PIRSF000451; PKS_III; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Fatty acid metabolism; Lipid metabolism;
KW   Reference proteome; Transferase.
FT   CHAIN           1..393
FT                   /note="Alpha-pyrone synthesis polyketide synthase-like
FT                   Pks18"
FT                   /id="PRO_0000407320"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        175
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:15286723"
FT   BINDING         221
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   SITE            205
FT                   /note="Important for broad specificity for aliphatic long-
FT                   chain acyl-CoA starter units"
FT   SITE            209
FT                   /note="Important for broad specificity for aliphatic long-
FT                   chain acyl-CoA starter units"
FT   MUTAGEN         144
FT                   /note="T->F: Completely abolishes the polyketide synthase
FT                   activity with lauroyl-CoA and palmitoyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         148
FT                   /note="A->F,M,T: Cannot be recovered in the soluble form."
FT                   /evidence="ECO:0000269|PubMed:12941968"
FT   MUTAGEN         175
FT                   /note="C->A: Loss of polyketide synthase activity."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         205
FT                   /note="C->A: No significant change in polyketide synthase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         205
FT                   /note="C->F: Efficiently catalyzed the synthesis of the
FT                   triketide pyrone of the C6 starter unit and shows weak
FT                   polyketide synthase activity with the C12 starter
FT                   molecule."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         209
FT                   /note="A->F: Retained reasonable polyketide synthase
FT                   activity with lauroyl-CoA but cannot use palmitoyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         275
FT                   /note="C->A: No significant change in polyketide synthase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15286723"
FT   MUTAGEN         318
FT                   /note="K->A: Unable to synthesize any polyketide products."
FT                   /evidence="ECO:0000269|PubMed:12941968"
FT   MUTAGEN         348
FT                   /note="L->S: Increase in the synthesis of the tetraketide
FT                   products."
FT                   /evidence="ECO:0000269|PubMed:12941968"
FT   STRAND          32..41
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           49..57
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           68..74
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           92..95
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          98..100
FT                   /evidence="ECO:0007829|PDB:1TEE"
FT   HELIX           102..125
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           132..134
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          135..144
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           151..159
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          166..172
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           174..176
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           177..191
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          196..204
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           215..223
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          226..236
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          247..256
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          263..269
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          272..277
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           281..299
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           304..306
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          310..312
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           317..327
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           331..334
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           335..344
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   HELIX           350..361
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          364..378
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   TURN            379..381
FT                   /evidence="ECO:0007829|PDB:1TED"
FT   STRAND          382..390
FT                   /evidence="ECO:0007829|PDB:1TED"
SQ   SEQUENCE   393 AA;  42032 MW;  317D24C33B9CFD42 CRC64;
     MNVSAESGAP RRAGQRHEVG LAQLPPAPPT TVAVIEGLAT GTPRRVVNQS DAADRVAELF
     LDPGQRERIP RVYQKSRITT RRMAVDPLDA KFDVFRREPA TIRDRMHLFY EHAVPLAVDV
     SKRALAGLPY RAAEIGLLVL ATSTGFIAPG VDVAIVKELG LSPSISRVVV NFMGCAAAMN
     ALGTATNYVR AHPAMKALVV CIELCSVNAV FADDINDVVI HSLFGDGCAA LVIGASQVQE
     KLEPGKVVVR SSFSQLLDNT EDGIVLGVNH NGITCELSEN LPGYIFSGVA PVVTEMLWDN
     GLQISDIDLW AIHPGGPKII EQSVRSLGIS AELAAQSWDV LARFGNMLSV SLIFVLETMV
     QQAESAKAIS TGVAFAFGPG VTVEGMLFDI IRR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024